commentary
Improving How Medicines R&D Is Financed Could Support Innovation and Benefits for Patients
Tackling chronic and infectious diseases depends to a large extent on the ability to develop innovative and affordable medicines that are available to patients in need. Policymakers will need to tackle challenges from multiple angles to avoid reducing barriers in one area at the expense of exacerbating challenges in another.
Read More »Aug 25, 2022
The RAND Blog